{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:32:13Z","timestamp":1792492333205,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.cyto.2013.03.021","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T11:21:23Z","timestamp":1366197683000},"page":"401-406","source":"Crossref","is-referenced-by-count":15,"title":["Anti-nociceptive effect of IL-12p40 in a rat model of neuropathic pain"],"prefix":"10.1016","volume":"62","author":[{"given":"I.-Fang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Noma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Hadlaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Teich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Benoliel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Eliav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cyto.2013.03.021_b0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0955-2235(92)90016-B","article-title":"Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation","volume":"4","author":"Trinchieri","year":"1992","journal-title":"Prog Growth Factor Res"},{"issue":"5107","key":"10.1016\/j.cyto.2013.03.021_b0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.8097338","article-title":"Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages","volume":"260","author":"Hsieh","year":"1993","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.cyto.2013.03.021_b0015","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.4049\/jimmunol.154.10.5071","article-title":"Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells","volume":"154","author":"Macatonia","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2013.03.021_b0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.16.1.495","article-title":"The interleukin-12\/interleukin-12-receptor system: role in normal and pathologic immune responses","volume":"16","author":"Gately","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2013.03.021_b0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0065-2776(01)79002-5","article-title":"Regulation of interleukin-12 production in antigen-presenting cells","volume":"79","author":"Ma","year":"2001","journal-title":"Adv Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2013.03.021_b0030","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.170.3.827","article-title":"Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes","volume":"170","author":"Kobayashi","year":"1989","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.cyto.2013.03.021_b0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-{gamma}: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"5","key":"10.1016\/j.cyto.2013.03.021_b0040","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1084\/jem.176.5.1387","article-title":"Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells","volume":"176","author":"D\u2019Andrea","year":"1992","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.cyto.2013.03.021_b0045","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.4049\/jimmunol.158.9.4381","article-title":"In vivo production and function of IL-12p40 homodimers","volume":"158","author":"Heinzel","year":"1997","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.cyto.2013.03.021_b0050","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/eji.1830230923","article-title":"The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer","volume":"23","author":"Mattner","year":"1993","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2013.03.021_b0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/eji.1830250133","article-title":"Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist","volume":"25","author":"Gillessen","year":"1995","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2013.03.021_b0060","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.4049\/jimmunol.165.11.6221","article-title":"IL-12 receptor beta 2 (IL-12R beta 2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites","volume":"165","author":"Wu","year":"2000","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2013.03.021_b0065","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.163.5.2902","article-title":"A novel function of IL-12p40 as a chemotactic molecule for macrophages","volume":"163","author":"Ha","year":"1999","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.cyto.2013.03.021_b0070","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.4049\/jimmunol.171.12.6866","article-title":"IL-12p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1","volume":"171","author":"Russell","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2013.03.021_b0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.193.3.339","article-title":"Interleukin 12p40 production by barrier epithelial cells during airway inflammation","volume":"193","author":"Walter","year":"2001","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.cyto.2013.03.021_b0080","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.4049\/jimmunol.169.5.2653","article-title":"A profibrotic function of IL-12p40 in experimental pulmonary fibrosis","volume":"169","author":"Huaux","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2013.03.021_b0085","first-page":"409","article-title":"Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies","volume":"3","author":"Atkins","year":"1997","journal-title":"Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.cyto.2013.03.021_b0090","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1200\/JCO.2003.12.119","article-title":"Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinoma","volume":"21","author":"Gollob","year":"2003","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.cyto.2013.03.021_b0095","first-page":"3686","article-title":"Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Mullerian carcinoma, gastrointestinal primary malignancies, and mesothelioma","volume":"8","author":"Lenzi","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.cyto.2013.03.021_b0100","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1200\/JCO.2001.19.18.3836","article-title":"Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma","volume":"19","author":"Lee","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.cyto.2013.03.021_b0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00262-002-0356-5","article-title":"IL-12: a promising adjuvant for cancer vaccination","volume":"52","author":"Portielje","year":"2003","journal-title":"Cancer Immunol Immun"},{"issue":"14","key":"10.1016\/j.cyto.2013.03.021_b0110","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1200\/JCO.2004.10.045","article-title":"Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma","volume":"22","author":"Alatrash","year":"2004","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.cyto.2013.03.021_b0115","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1200\/JCO.2005.00.463","article-title":"Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas","volume":"23","author":"Mazzolini","year":"2005","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.cyto.2013.03.021_b0120","first-page":"3686","article-title":"Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Mullerian carcinoma, gastrointestinal primary malignancies, and mesothelioma","volume":"8","author":"Lenzi","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.cyto.2013.03.021_b0125","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00002371-200307000-00006","article-title":"Phase 1 study of the intravesical administration of recombinant human interleukin-12 in patients with recurrent superficial transitional cell carcinoma of the bladder","volume":"26","author":"Weiss","year":"2003","journal-title":"J Immunother"},{"issue":"6","key":"10.1016\/j.cyto.2013.03.021_b0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1089\/104303401300057388","article-title":"Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study","volume":"12","author":"Kang","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cyto.2013.03.021_b0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1479-5876-5-66","article-title":"Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease<1cm) associated with ovarian cancer or primary peritoneal carcinoma","volume":"5","author":"Lenzi","year":"2007","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.cyto.2013.03.021_b0140","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1124\/jpet.105.089409","article-title":"Nociceptive effect of subcutaneously injected interleukin-12 is mediated by endothelin (ET) acting on ETB receptors in rats","volume":"315","author":"Verri","year":"2005","journal-title":"J Pharm Exp Ther"},{"issue":"1","key":"10.1016\/j.cyto.2013.03.021_b0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.cyto.2013.03.021_b0150","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0304-3959(94)90013-2","article-title":"Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve","volume":"57","author":"Tal","year":"1994","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2013.03.021_b0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pain.2007.01.015","article-title":"Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception","volume":"132","author":"Ahn","year":"2007","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.cyto.2013.03.021_b0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejpain.2007.07.002","article-title":"Intramuscular administration of morphine reduces mustard-oil-induced craniofacial-muscle pain behavior in lightly anesthetized rats","volume":"12","author":"Han","year":"2008","journal-title":"Eur J Pain"},{"issue":"3","key":"10.1016\/j.cyto.2013.03.021_b0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.cyto.2013.03.021_b0170","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bbi.2009.01.012","article-title":"The role of IL-6 and IL-1[beta] in painful perineural inflammatory neuritis","volume":"23","author":"Eliav","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.cyto.2013.03.021_b0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3727\/000000007783992807","article-title":"Cytokine-induced pain: basic science and clinical implications","volume":"9","author":"Uceyler","year":"2007","journal-title":"Rev Analgesia"},{"issue":"3","key":"10.1016\/j.cyto.2013.03.021_b0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pain.2005.04.018","article-title":"Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain","volume":"116","author":"Zelenka","year":"2005","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.cyto.2013.03.021_b0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1471-4892(01)00010-8","article-title":"Neurotrophic factors and neuropathic pain","volume":"1","author":"Boucher","year":"2001","journal-title":"Curr Opin Pharm"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2013.03.021_b0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3959(99)00262-6","article-title":"Nociceptive and inflammatory effects of subcutaneous TNFalpha","volume":"85","author":"Junger","year":"2000","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.cyto.2013.03.021_b0195","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1046\/j.1460-9568.1999.00641.x","article-title":"Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice","volume":"11","author":"Murphy","year":"1999","journal-title":"Eur J Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2013.03.021_b0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(99)01782-5","article-title":"Brain-derived TNFalpha mediates neuropathic pain","volume":"841","author":"Ignatowski","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.cyto.2013.03.021_b0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000058694","article-title":"Regulation of IL-12 receptor expression in early T-helper responses implies two phases of Th1 differentiation: capacitance and development","volume":"68","author":"Murphy","year":"1997","journal-title":"Chem Immunol"},{"issue":"18","key":"10.1016\/j.cyto.2013.03.021_b0210","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1097\/00001756-199611250-00018","article-title":"Endoneurial injection of TNF-alpha produces neuropathic pain behaviors","volume":"7","author":"Wagner","year":"1996","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.cyto.2013.03.021_b0215","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1460-9568.1996.tb01237.x","article-title":"Interleukin 6 in intact and injured mouse peripheral nerves","volume":"8","author":"Reichert","year":"1996","journal-title":"Eur J Neurosci"},{"issue":"9","key":"10.1016\/j.cyto.2013.03.021_b0220","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/jir.1996.16.695","article-title":"Interleukin-6-mediated hyperalgesia\/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model","volume":"16","author":"DeLeo","year":"1996","journal-title":"J Interf Cytok Res"},{"issue":"7","key":"10.1016\/j.cyto.2013.03.021_b0225","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1476-5381.1995.tb15035.x","article-title":"Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia","volume":"115","author":"Safieh-Garabedian","year":"1995","journal-title":"Br J Pharm"},{"issue":"3","key":"10.1016\/j.cyto.2013.03.021_b0230","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2011.01.079","article-title":"Interleukin-17 levels in rat models of nerve damage and neuropathic pain","volume":"493","author":"Noma","year":"2011","journal-title":"Neuroscience Lett"},{"issue":"10","key":"10.1016\/j.cyto.2013.03.021_b0235","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1002\/1521-4141(2001010)31:10<3101::AID-IMMU3101>3.0.CO;2-8","article-title":"Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases","volume":"31","author":"Chiodoni","year":"2001","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2013.03.021_b0240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-3083.1999.00560.x","article-title":"Inflammation and severe demyelination in the peripheral nervous system induced by the intraneural injection of recombinant mouse interleukin-12","volume":"50","author":"Pelidou","year":"1999","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2013.03.021_b0245","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuroscience.2004.07.035","article-title":"Interleukin-12p40-homodimer production in sensory dorsal root ganglion neurons","volume":"129","author":"Hikawa","year":"2004","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.cyto.2013.03.021_b0250","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1074\/jbc.M008262200","article-title":"Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12p40 in microglial cells","volume":"276","author":"Pahan","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.cyto.2013.03.021_b0255","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1471-4159.2003.01864.x","article-title":"Induction of tumor necrosis factor-alpha (TNF-alpha) by interleukin-12p40 monomer and homodimer in microglia and macrophages","volume":"86","author":"Jana","year":"2003","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.cyto.2013.03.021_b0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.it.2006.11.002","article-title":"IL-12p40: an inherently agonistic cytokine","volume":"28","author":"Cooper","year":"2007","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2013.03.021_b0265","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2131\/jts.28.35","article-title":"Pharmacological evaluation of garenoxacin, a novel des-F(6)-quinolone antimicrobial agent: effects on the central nervous system","volume":"28","author":"Nakamura","year":"2003","journal-title":"J Toxicol Sci"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466613001403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466613001403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T03:50:44Z","timestamp":1688183444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466613001403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1043466613001403"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2013.03.021","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}